CLINICAL_TRIALS
trial_result
· 2022-11-23
Clinical Trial Update: Study of VYNT-0126 in the Treatment of Rett Syndrome in Adult Patients [Phase 2]
Summary
Phase 2 clinical trial update for VYNT-0126 in adults with Rett Syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vyant Bio | Conditions: Rett Syndrome | Phase 2 | Status: UNKNOWN